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Norepinephrine (NE), the primary neurotransmitter of the sympathetic nervous system, has been reported to be a chemoattrac-
tant for enterohemorrhagic Escherichia coli (EHEC). Here we show that nonpathogenic E. coli K-12 grown in the presence of 2
MNE is also attracted to NE. Growth with NE induces transcription of genes encoding the tyramine oxidase, TynA, and the
aromatic aldehyde dehydrogenase, FeaB, whose respective activities can, in principle, convert NE to 3,4-dihydroxymandelic acid
(DHMA). Our results indicate that the apparent attractant response to NE is in fact chemotaxis to DHMA, which was found to be
a strong attractant for E. coli. Only strains of E. coli K-12 that produce TynA and FeaB exhibited an attractant response to NE.
We demonstrate that DHMA is sensed by the serine chemoreceptor Tsr and that the chemotaxis response requires an intact ser-
ine-binding site. The threshold concentration for detection is<5 nMDHMA, and the response is inhibited at DHMA concentra-
tions above 50M. Cells producing a heterodimeric Tsr receptor containing only one functional serine-binding site still respond
like the wild type to low concentrations of DHMA, but their response persists at higher concentrations. We propose that che-
motaxis to DHMA generated fromNE by bacteria that have already colonized the intestinal epitheliummay recruit E. coli and
other enteric bacteria that possess a Tsr-like receptor to preferred sites of infection.
The human gastrointestinal (GI) tract harbors an assortment ofbacteria, most of which are harmless or helpful commensals.
However, infection of the GI tract by pathogenic bacteria can have
devastating consequences. It has been suggested that norepineph-
rine (NE), the predominant neurotransmitter of the enteric sym-
pathetic nervous system, promotes growth and virulence of en-
teric bacteria (1) through signaling via adrenergic receptors
located either on intestinal epithelial cells (2) or in the bacteria
themselves (3, 4). In particular, the bacterial quorum sensor ki-
nase QseC has been implicated in the NE-induced expression of
genes whose products are involved in adherence, motility, and
pathogenesis (4, 5). However, the concentrations of NE required
for effective induction of virulence genes, 50 M in one recent
study (6), are higher than those that are expected to occur in the
intestinal lumen (7, 8). Thus, for NE to activate expression of
virulence factors, bacteria would have to navigate to regions of the
intestinal epithelium that have locally high concentrations of NE.
An obvious candidate for directing such migration is chemotaxis.
Chemotaxis in Escherichia coli is well understood at the molec-
ular level. However, the compounds that have been reported as
chemoattractants (9) are primarily nutrients: serine and related
amino acids, sensed by the chemoreceptor Tsr; aspartate and
maltose, sensed by Tar; ribose and galactose, sensed by Trg; and
dipeptides and pyrimidines, sensed by Tap. NE has been reported
to be an interdomain signaling molecule (5, 10, 11). NE serves
as an inducer of virulence and motility genes in enterohemor-
rhagic E. coli (EHEC) and in Salmonella enterica (6, 10). The pri-
mary signaling pathway for induction of virulence appears to go
through the membrane-bound quorum-sensing kinase QseC and
its associated response regulator, QseB (12). The relationship be-
tween stress and microbial infection suggests that increased cate-
cholamine concentrations in the intestine promote bacterial
growth (13) and colonization (14). However, the effects of NE in
enhancing virulence require higher concentrations than those that
are predicted to exist in the gut, and in some cases, they appear to
be independent of QseC and instead related to the ability of NE to
serve as an iron chelator (15). However, both- and-adrenergic
receptor antagonists inhibit the responses of enteric bacteria to
catecholamines, and receptors other than QseC, including QseE,
BasS, and CpxA, have been reported to contribute to the bacterial
response to adrenergic signals (5). The current study was under-
taken to determine themechanisms underlying chemotaxis to NE
as a first step toward investigating whether chemotaxis contrib-
utes to the virulence of enteric bacteria.
MATERIALS AND METHODS
Bacterial strains and solutions. Strain CV1 is equivalent to strain RP437
(16) but was renamed to conform to the nomenclature of other strains
used in this study. It was used as thewild-typeE. coli strain for chemotaxis.
All relevant strains and plasmids are listed in Table 1. Liquid cultures were
grown in tryptone broth (TB; 10 g/liter tryptone and 8 g/liter NaCl).
Selection for kanamycin resistance was done on Luria-Bertani agar con-
taining 1.2% Difco Bacto agar and 50 g/ml kanamycin. TB semisolid
agar contained 0.35% Difco Bacto agar. H1 minimal-glycerol TLHMB1
agar contained 1.2% Difco Bacto agar and was supplemented with 0.5%
glycerol, 20 g/ml (each) threonine, leucine, histidine, and methionine,
and 1g/ml thiamine. Chemotaxis buffer (CB) consisted of physiological
buffered saline with 10 mM potassium phosphate, pH 7.0, containing 0.1
mM EDTA, 0.01 mM L-methionine, and 10 mM DL-lactate. Expression of
Tsr from plasmids pCA24N-tsr and pRR53-tsrR69E was induced with 100
M isopropyl--D-thiogalactopyranoside (IPTG). This concentration of
inducer gave optimal serine chemotaxis in tryptone semisolid agar when
wild-type Tsr was expressed from pCA24N-tsr in the tsr strain CV5.
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Reagents. 3,4-Dihydroxymandelic acid (DHMA; 98% pure) was ob-
tained from Sigma-Aldrich, and norepinephrine (99.5% purity) was
obtained from Calbiochem.
Generation of mutants. The tynA, feaB, and qseC kan-insertion
knockout mutations in strains SP101 to -103 were introduced into strain
CV1 by phage P1vir transduction from the respective mutants in the Keio
collection (17), with selection for resistance to 50 g/ml kanamycin. The
insertions were confirmed by Southern blotting. Chromosomal tsr point
mutations were introduced into strain CV1 in two steps. First, a serB-kan
insertion from strain UU2641 was introduced into strain CV1 by P1vir
transduction, with selection for resistance to 50 g/ml kanamycin on
Luria broth (LB) agar, to generate strain TAMU100. The tsr mutations
were then introduced into strain TAMU100 by P1vir transduction with
lysates prepared on strains UU2375 andUU2376, which contain chromo-
somal tsr alleles encoding Tsr-R69E and Tsr-T156K, respectively, to gen-
erate strains TAMU101 and TMAU102. Selection for Ser transductants
was accomplished by plating onminimal-glycerol TLHMB1 agar, and the
presence of the tsrmutations was screened by testing transductants on TB
semisolid agar and picking isolates that did not form the outer (serine)
chemotaxis ring. Glycerol was used as the carbon source in minimal me-
dium because glucose adventitiously induces transcription of the ccdB
(control of cell death) gene from the rhaB promoter in the kan insertion
that allows counterselection for loss of the insertion in the presence of
rhamnose (18). CcdB is a potent gyrase inhibitor (19) that is the toxin of
an addiction system of the F plasmid of E. coli (20).
Fabrication of microflow devices.Microflow devices were fabricated
as previously described (21). Briefly, device designs were drawn in Auto-
CAD and used to create a high-resolution (3,000 dots per in. [dpi])
photolithography mask with a laser printer (Advanced Reproductions,
North Andover, MA). Standard photolithography techniques using an
SU-8 2050 photoresist (MicrochemCorp.,MA) generated imprints of the
microflowdevices on siliconwafers. The siliconwafer templateswere used
as negative molds to generate the chemotaxis devices in poly(dimethyl)
siloxane (PDMS), using standard soft-lithography protocols (21). Cham-
ber dimensions were measured using a profilometer. Devices were fabri-
cated by bonding the patterned PDMS slab to clean glass slides, using
oxygen-plasma bonding in a plasma etcher (100 mtorr, 100 W, 40 s) to
create optically transparent devices. Access ports were punched into the
PDMS by use of a blunt 19-gauge needle.
Microflow assay. The microflow assay for chemotaxis (21) measures
the chemotaxis response of bacteria fluorescently labeled by green fluo-
rescent protein (GFP) expression. When the cells enter the observation
chamber, they encounter a stable concentration gradient of chemoeffec-
tor established across the width of the microfluidic chamber. The micro-
flow chemotaxis device consists of twomodules: a concentration gradient
generator and a chemotaxis observation chamber. The gradient generator
comprises a network of microfluidic channels that uses diffusive mixing
from five inputs to generate nonlinear, approximately exponential con-
centration gradients across the width of the observation chamber. The
length of the network is 18.5 mm. The width of each inlet entering the
observation chamber is 500 m. The observation module is a chamber
(20m 1,050m 2 cm) connected to the gradient generatormodule.
A secondary inlet (50 m) is used to introduce bacteria into the observa-
tion module at the midpoint of the concentration gradient. The bacteria
and the concentration gradients are introduced into the device through
silicon tubing. The device infused with dyes of different colors is shown in
Fig. S1 in the supplemental material.
The assay was performed as described previously (21). A mixture of
GFP-expressing, motile test cells and red fluorescent protein (RFP)-con-
taining, dead TG1 cells was gently resuspended in CB containing the che-
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Relevant genotype or other characteristics
Antibiotic
resistancea Source or reference
E. coli strains
CV1 Wild type for chemotaxis; equivalent to RP437 thr-1(Am) leuB6 his-4 metF159(Am)
rpsL136 [thi-1 ara-14 lacY1 mtl-1 xyl-5 eda tonA31 tsx-78]
Str 16
CV5 CV1 tsr thr Str 50
CV12 CV1 (tar-tap)5201 trg::Tn10 eda Str, Tet 50
CV16 CV1 tsr thr (tar-tap)5201 trg::Tn10 eda Str, Tet 50
BW25113 tynA BW25113 tynA	Kan Kan 17
BW25113 feaB BW25113 feaB	Kan Kan 17
BW25113 qseC BW25113 qseC	Kan Kan 17
SP101 CV1 tynA Str, Kan This study
SP102 CV1 feaB Str, Kan This study
SP103 CV1 qseC Str, Kan This study
UU2641 RP437 serB::kan-ccdB Str, Kan J. S. Parkinson, personal
communication
UU2375 RP437 tsr-R69E (tar-tap)5201 (aer)1 ygjG::Gm (trg)4543 Str Parkinson, personal
communication
UU2376 RP437 tsr-R69E (tar-tap)5201 (aer)1 ygjG::Gm (trg)4543 Str Parkinson, personal
communication
TAMU100 CV1 serB::kan-ccdB This study
TAMU101 CV1 tsr-R69E This study
TAMU102 CV1 tsr-T156K This study
TAMU104 TAMU101/pRR53-tsrR69E This study
TG1 supE thi-1 (lac-proAB) (mcrB-hsdSM)5 (rK

mK

) F= [traD36 proAB lacIq
lacZM15]
Stratagene
Plasmids
pCM18 GFP expression vector Erm 51
pDS-Red Express RFP expression vector Amp Clontech
pRR53-tsrR69E Expresses Tsr-R69E under the control of IPTG Amp 36
a Abbreviations: Str, streptomycin; Tet, tetracycline; Kan, kanamycin; Erm, erythromycin; Cm, chloramphenicol; Amp, ampicillin.
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moeffector at the concentration expected at the midpoint of the observa-
tion chamber and incubated for 20min. All steps were conducted at room
temperature. The flow rate in themicrofluidic device was controlled using
a PicoPlus programmable pump (Harvard Apparatus, Holliston, MA).
The assembled device was positioned on the stage of a Leica TCS SP5
resonant-scanner confocal microscope. Multiple 500-l gas-tight glass
syringes (Hamilton, Reno, NV), containing either CB or CB with che-
moeffector, were carefully connected to the inlets of the gradient genera-
tor module to avoid introducing air bubbles into the device. The bacterial
mixture was introduced into the chemotaxis chamber through the bacte-
rial inlet port, using a 50-l gas-tight glass syringe. The syringes connected
to the gradient generator and the bacterial inlet were operated at the same
flow rate, using different pumps. The total flow rate in the observation
module (from the five gradient inlets and one bacterial inlet) was main-
tained at 2.1 l/min. Green and red fluorescent images were acquired for
20 min. For each experiment, 100 images for each fluorophore were col-
lected 7 mm from the inlet at 2.5-s intervals. The 2.5-s imaging interval
was chosen based on our calculation that free-floating bacteria moving at
a flow rate of 2.1l/min take an average of 2.5 to 3 s to traverse 1,000m,
the imaging field of view (21). Therefore, bacteria in themiddle of the flow
were exposed to the gradient for an average of 18 to 21 s prior to imaging.
Cells spendingmore time in contact with the floor or ceiling of the cham-
ber move more slowly (22).
Quantification of chemotaxis in the microflow assay with image
analysis. The migration and distribution of bacteria in each image were
quantified using a Matlab (Mathworks, Natick, MA) image analysis sub-
routine developed in-house, as described previously (21). Briefly, the
analysis consisted of the following steps: (i) removal of background pixels
in the image, based on pixel size and intensities; (ii) determination of the
center of the image (i.e., where bacteria enter the observation chamber),
using dead cells (red fluorescence) as a reference; (iii) location of green
cells (i.e., live bacteria expressingGFP) in the images relative to the center,
determined by calculating the centroid; and (iv) quantification of the
number of live cells in 16-m-wide intervals. These steps were repeated
for each image, and the total counts of cells in 100 images were summed
for analysis. The images shown in Fig. 7 and in Fig. S2 in the supplemental
material show the 100 images combined into a single composite image.
The migration profile was used to calculate the chemotaxis migration
coefficient (CMC), which weights the migration of cells by the distance
they move from the center of the observation chamber, as previously
described (23). For example, a cell that moves to the farthest high-con-
centration position at the right (interval 64) receives a weighting factor of
1, and a cell thatmoves to the farthest low-concentration position at the
left (interval 1) is given a weighting factor of
1. Green cells in themiddle
of the chamber (intervals 31 to 34) were excluded from the analysis on the
grounds that they could be nonmotile or poorly motile cells. The motility
migration coefficient (MMC) was determined in the same way, except
that the weighting factor was positive in both directions. Examples of
assays used to calculate CMC andMMC values are shown in Fig. S2 in the
supplemental material.
The CMC value represents the magnitude of the chemotaxis response
to the steep exponential gradients that are generated with 10-fold in-
creases in the attractant concentration in each of the five inlet ports, from
left to right. The cells were preincubated for 10 min with the same con-
centration of attractant present in the middle (third) inlet, which is the
concentration they experience when entering the chamber. The MMC
value represents the extent of the smooth-swimming response of cells in
CB that are introduced into a chamber with a uniform concentration of
attractant. The cells do not adapt to the attractant until they spread across
the chamber. If they adapt before reaching the point along the channel at
which their distribution is imaged, their movement will be random run-
and-tumble behavior that will not significantly affect the final distribution
across the chamber.
Preparation of motile bacteria for chemotaxis assays. Bacteria were
prepared for chemotaxis assays as described byMao et al. (23). Cultures of
GFP-expressing bacteria, grown overnight at 32°C in TB containing 150
g/ml erythromycin, were inoculated into 25 ml of the same medium
lacking erythromycin to a turbidity at 600 nm of 0.05. Cultures were
grownwith swirling in 125-ml Erlenmeyer flasks at 32°C tomid-exponen-
tial phase (turbidity at 600 nm of 0.5), with the addition of 100 M
IPTG for induction of Tsr expression from the pRR53-tsr andpCA24N-tsr
plasmids. A 3-ml aliquot of cells was centrifuged at 400  g for 5 min at
room temperature and gently resuspended in 2 ml of CB. TG1 cells ex-
pressing RFP were killed by exposure to 1 mM kanamycin for 1 h (com-
plete killingwas verified by a lack of growth on LB agar plates), thoroughly
washed with CB, and mixed with GFP-expressing motile cells at approx-
imately equal densities. The microflow chemotaxis assay was performed
within 20 min after resuspension of the bacteria in CB, which contained
attractants at the concentration expected at the midpoint of the observa-
tion chamber, e.g., 500 nM in a 0- to 50-Mexponential gradient. In some
experiments, bacteria were prepared as described above but primed by
addition of 2 M NE to the TB growth medium 1 h before harvesting.
Cells introduced into uniform concentrations of attractants were resus-
pended in nonsupplemented CB, except as noted.
RNA isolation and qRT-PCR.Bacteria were grown using the protocol
described above for the microflow assay, with or without priming. After
60 min of exposure to NE, cells were collected by centrifugation and
stored at 
80°C prior to RNA extraction. RNA was extracted using a
Nucleospin RNA II kit (Clontech, CA) according to the protocol recom-
mended by the manufacturer. Cells grown without NE were used as neg-
ative controls. Total RNA was isolated from the cell pellets, and RNA
quality was assessed spectrophotometrically. Quantitative reverse tran-
scription-PCR (qRT-PCR) was performed using an iScript one-step RT-
PCR kit with SYBR green (Bio-Rad Laboratories, CA) on a MyiQ single-
color real-time PCR detection system (Bio-Rad Laboratories). The
threshold cycles calculated by theMyiQ optical system software (Bio-Rad
Laboratories) were used to determine the relative changes between sam-
ples. The experiments were run in triplicate in 25-l reaction mixtures,
and 50 ng of total RNA was used for each reaction mixture, with a final
forward and reverse primer concentration of 0.15 M (each). After am-
plification, template specificity was ensured through melting curve anal-
ysis. The rrsG (rRNAG) transcript was used as the housekeeping RNA for
normalizing the data.
Determination of the number of molecules of DHMA in the
periplasm. The mean volume of an E. coli cell grown in a moderately rich
medium, such as TB, has been estimated to be around 4 fl (24), and the
volume of the periplasm has been estimated to be 20 to 40% of the total
cell volume (25). Thus, 1  10
15 liter is a reasonable estimate for the
average periplasmic volume. At 5 nM (5 10
9 mol/liter), a concentra-
tion of DHMA that still generates an attractant response, there are thus
about 5 10
24 mol of DHMA in the periplasm, assuming equilibration
with the external medium. Multiplying by Avogadro’s number (6 1023
molecules/mol), this yields about 3 molecules of DHMA in the periplas-
mic space of a single cell.
RESULTS
An E. coliK-12 strain shows chemotaxis towardNE.To examine
NE chemotaxis, we used theK-12 strainRP437 (16), a standard for
studies of E. coli chemotaxis. Strain RP437 is henceforth called
CV1 to conform to the nomenclature used for the chemoreceptor
mutant strains used in this study.
We employed a microflow device manufactured in-house (21)
tomonitor chemotaxis to NE. This assay offers several advantages
for studying the response to biological signals. First, themicroliter
volumes involved minimize the amount of a chemical that must
be used per assay. Second, the migration of bacteria can be ob-
served in stable gradients of almost any desired profile. These gra-
dients are established in a mixing device and are oriented perpen-
dicular to the direction of flow. Third, because the microflow
Pasupuleti et al.
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chamber is only 1 mm wide, the gradients formed can be very
steep. Finally, the time for the bulk flow to reach the site of imag-
ing is20 s, so the short-term responses of cells can be recorded.
Cells harvested from TB did not respond to NE in the micro-
flow assay, in contrast to the results of earlier reports with a mi-
croplug assay (10). However, in the microplug assay, cells are ex-
posed to NE for 30 min or longer. We therefore tested whether
prior exposure to NE primes cells to respond. Cells grown in TB
supplemented with 2 M NE for 1 h before harvesting showed a
robust response to NE (Fig. 1) that was equivalent to the response
observed with similar gradients of serine (Fig. 1; see Fig. S2 in the
supplemental material). The effects of preexposure to NE were
eliminated when 12.5 g/ml chloramphenicol was added at the
same time as NE, suggesting that protein synthesis is required for
the effect (Fig. 1). Chemotaxis to serine and aspartate, sensed as
attractants by the Tsr and Tar chemoreceptors, respectively, was
unaffected by chloramphenicol. These results suggest that prein-
cubation with NE induces the synthesis of proteins that are re-
quired for NE to be sensed as an attractant.
Chemotaxis toward NE requires induction of bacterial en-
zymes.One pathway for NEmetabolism inmammals involves deami-
nation to form3,4-dihydroxyphenyl-glycol-aldehyde (DOPEGAL) fol-
lowed by oxidation to form3,4-dihydroxymandelic acid (DHMA)
(26). These steps in E. coli can potentially be carried out by two
enzymes: a periplasmic tyramine oxidase, TynA (27), and a cyto-
plasmic aromatic aldehyde dehydrogenase, FeaB (27). qRT-PCR
analysis showed that tynA transcription increased 4.5-fold and
feaB transcription increased 3.5-fold after 1 h of incubation with
2 M NE (Fig. 2B). The SP101 and SP102 mutants, which lack
TynA and FeaB, respectively, failed to respond to NE in the mi-
croflow assay (Fig. 3).
The quorum-sensing kinase QseC has been implicated in NE-
induced expression of virulence and motility genes in pathogenic
E. coli and S. enterica (4, 5). Induction of tynA and feaB transcrip-
tion by exposure to NE was abolished in the qseCmutant SP103
(Fig. 2B), which also showed a large decrease in NE chemotaxis
(Fig. 3). These results suggest that NE sensed by QseC induces
tynA and feaB transcription, and hence production of DOPEGAL
and DHMA.
DHMA is a potent attractant for E. coli. DOPEGAL is not
FIG 1 CMC values for cells in exponential gradients of 1 to 500 MNE and 1
to 200Mserine and aspartate. Error bars represent the standard deviations of
the means for results from triplicate experiments. Primed cells were grown in
the presence of 2 M NE for 1 h before harvesting. Abbreviations: CB, che-
motaxis buffer; NE, norepinephrine; Asp, aspartate; Ser, serine; Cam, chlor-
amphenicol. *, not assayed.
FIG 2 Bacterial genes encode enzymes that can produce DHMA from NE. (A) The chemical pathway shown is present in the human GI tract, and E. coli
potentially has a similar capability via TynA and FeaB, as indicated. (B) Induction of tynA and feaB transcription by preincubation with 2 MNE in wild-type
andqseC cells. The levels of transcript weremeasured by qRT-PCR60min after addition of 2MNE to the culture for 1 h. Controls were grownover this period
in the absence of NE. The results are normalized to the level of the rrsG transcript. The error bars represent the standard deviations of the means.
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commercially available, but DHMA proved to be a very strong
attractant for strain CV1 (Fig. 4). Representative images of the
microflow assays with DHMA are shown in Fig. S2 in the supple-
mental material. The response to DHMA was strongest in an ex-
ponential gradient of 0 to 50 M. The CMC value was 0.12 in a
gradient of 0 to 5 M, 0.22 in a gradient of 0 to 50 M, 0.09 in a
gradient of 0 to 500 M, and 0.06 in a gradient of 0 to 5,000 M
(Fig. 4). The simplest explanation for the decreased response at
higher concentrations of DHMA is that the receptor became sat-
urated. Strain CV12, which contains only Tsr and Aer, gave a
much weaker response to DHMA. This difference may be due to
altered ligand sensitivity in strains that contain only one type of
high-abundance chemoreceptor (28, 29). Note that this response
is highly unlikely to be an aerotactic response through Aer, as
strains lacking a functional Tsr receptor did not show any re-
sponse in the microfluidic assay. Moreover, the device is not de-
signed to either generate or maintain gaseous gradients within the
flow chamber, as has been reported by Adler et al. (30).
Chemotaxis to DHMA requires the Tsr chemoreceptor and
its intact serine-binding site. CV5 cells that lack Tsr did not re-
spond to serine or DHMA, although their response to aspartate
was the same as that of CV1 cells (Fig. 5). We then tested whether
the serine-binding site of Tsr is required for sensing DHMA. The
T156K and R69E amino acid replacements in Tsr disrupt the ma-
jority and minority halves, respectively, of the serine-binding site
(31). Strains TAMU101 and TAMU102, which encode Tsr-R69E
and Tsr-T156K, respectively, at the chromosomal tsr locus, also
failed to respond to serine or DHMA in the microflow assay (Fig.
5). This analysis suggests that theDHMA- and serine-binding sites
in Tsr overlap.
HeterodimericTsrwith one functional ligand-binding siteme-
diates responses toDHMA.Tsr contains two rotationally symmet-
ric serine-binding sites that exhibit strong negative cooperativity
(32) (Fig. 6A). We therefore tested the possibility that binding of
DHMA at the second site inhibits the attractant signal produced
by binding at the first site. The Tsr-T156K and Tsr-R69E mutant
subunits were produced at approximately equal levels in strain
TAMU104 (see Materials andMethods). In this strain, the T156K
FIG 3 NE chemotaxis in mutants defective in NE metabolism. CMC values
are shown for exponential gradients of 0 to 500MNEand 0 to 200Mserine.
Strains: CV1, wild type; SP101, tynA strain; SP102, feaB strain; SP103,
qseC strain. Error bars represent the standard deviations of the means for
results from triplicate experiments. Primed cells were grown in the presence of
2 M NE for 1 h before harvesting. *, not assayed.
SP
10
3
FIG 4 CMC values for cells in exponential DHMA gradients. The gradients
ranged from 0 to the indicated value, in M. Strains: CV1, wild type; CV12,
tar-tap trg strain; SP101, tynA strain; SP103, qseC strain. Error bars
represent the standard deviations of the means for results from triplicate ex-
periments. Primed cells were grown in the presence of 2MNE for 1 h before
harvesting.
FIG 5 DHMA chemotaxis in tsr mutant strains. CMC values are shown for
exponential gradients of 0 to 50 M DHMA and 0 to 200 M serine. Strains:
CV1, wild type; CV5, tsr strain; TAMU101, tsr-R69E strain; TAMU102, tsr-
T156K strain; TAMU104, strain expressing a chromosomal tsr-T156K gene
and a plasmid-borne tsr-R69E gene at approximately the same levels. CMC
values are also given for TAMU104 in gradients of 0 to 500 M and 0 to 5,000
MDHMA for comparison with the CMC values in those gradients for strain
CV1 shown in Fig. 4. Error bars represent the standard deviations of themeans
for results from triplicate experiments. Primed cells were grown in the pres-
ence of 2 mM NE for 1 h before harvesting. *, not assayed.
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protein is expressed from the chromosomal tsr locus, and the
R69E protein is expressed from a plasmid-carried tsr gene under
the control of an IPTG-inducible promoter. After induction with
100 M IPTG, this strain produces approximately the same
amount of Tsr as the chromosomal gene. Under these conditions,
half of the Tsr molecules should be heterodimers with one intact
ligand-binding site and one doubly defective site (Fig. 6B). A sim-
ilar approach has been used to show that Tar (33, 34) and Tsr (35,
36) heterodimers of this type still mediate attractant responses to
their respective ligands. In contrast to CV1 cells, TAMU104 cells
exposed to 100 M IPTG responded robustly to DHMA in gradi-
ents of 0 to 50Mup to 0 to 5,000M(Fig. 5). Thus, whenTsr has
only one functional ligand-binding site, it mediates good che-
motaxis responses at higher concentrations of DHMA.
In a second assay, cells resuspended in CB in the absence of
DHMA were introduced into a microflow chamber containing
various uniform concentrations of DHMA in CB. In this assay, a
smooth-swimming response is indicated by enhanced spreading
of cells in both directions from themidpoint, where they enter the
channel. This spreading is quantified in a termwe call themotility
migration coefficient (MMC) (see Materials and Methods). The
difference in the responses used to determine the CMC andMMC
values is illustrated in Fig. 7A, and the full spectrum of responses
to uniform concentrations of DHMA and serine is presented in
Fig. S2 in the supplemental material. A more complete discussion
of the behaviors quantified in the CMC and MMC assays is given
in Materials and Methods, under the heading “Quantification of
chemotaxis in the microflow assay with image analysis.”
Wild-type CV1 cells had anMMC value of 0.16 in CB. In com-
parison, exclusively smooth-swimming CV16 cells, which lack all
four canonical chemoreceptors, had anMMC value of 0.40 in CB.
The increased spreading of smooth-swimming cells probably oc-
curs because they rapidly reach the floor or ceiling of the 20-m-
tall chamber and move laterally in the channel without being
caught up in the bulk flow, which would quickly wash them
through the chamber. Thus, they have more time to spread across
the width of the chamber.
As shown in Fig. 7B, CV1 and TAMU104 cells already showed
increased MMC values at 5 nM (0.0005 M) DHMA, whereas
TAMU101 (TsrR69E) and TAMU102 (TsrT156K) cells first showed
increased MMC values at 500 nM (0.5 M) and 5 M DHMA,
respectively. Thus, the two point mutations in tsr do not make the
cells totally unresponsive to DHMA, but they decrease the re-
sponse sufficiently to prevent detectably higher CMC values in
exponential DHMA gradients in our microflow assay. CV1 cells
introduced into the chamber after being exposed to DHMA for 20
min at the same concentration as that they encountered in the
chamber did not show MMC values above 0.16 at any DHMA
FIG 6 Complementation of mutations that disrupt themajority andminority
half-binding sites for serine in the Tsr dimer. (A) Periplasmic domain of the
wild-type Tsr homodimer. Squares indicate the majority site, and triangles
indicate the minority site. The receptor monomers are shown in blue, and the
ligands are shown in orange, with the square end representing the -amino
and -carboxyl groups of the amino acid ligand and the pointed end repre-
senting the R group. Ligands can bind with equal affinities to either of the
rotationally symmetric binding sites. Both sites can be occupied, but binding
to the second typically occurs with strong negative cooperativity. (B) The
residue substitutions introduced by mutations, indicated by the red X’s, are
T156K for the majority site and R69E for the minority site. Neither mutant
homodimer is capable of binding ligand. If the two mutant receptors are co-
expressed at equal levels, half of the Tsr dimers will be heterodimers (T156K/
R69E) that retain one intact ligand-binding site.
FIG 7 (A) Representative images of the microflow assay illustrating both CMC andMMC assays. (Top left) CB only; (top right) exponential gradient of 0 to 50
MDHMA; (bottom left) uniform concentration of 500 nMDHMA; (bottom right) uniform concentration of 500 nM serine. (B)MMC values for different tsr
mutants in exponential gradients of DHMA from 0 to the indicated concentration, in M. Strains: CV1, wild type; TAMU101, tsr-R69E strain; TAMU102,
tsr-T156K strain; TAMU104, strain with chromosomal tsr-T156K and plasmid-borne, salicylate-inducible tsr-R69E. Error bars represent the standard deviations
of the means for results from triplicate experiments.
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concentration, so the cells did adapt to the presence of DHMA, as
they do to serine.
CV1 cells first showed an increase in MMC value at 500 nM
serine, indicating that Tsr senses DHMA about 100 times more
sensitively than it senses serine (Fig. 8). The MMC values for ser-
ine plateaued at 5 M and remained between 0.40 and 0.45 up to
5mM.TheMMCvalues plateaued at 0.5 to 0.55with 0.5 and 5M
DHMA but then dropped significantly at 500 M DHMA. The
MMC values at 500Mand 5mMDHMAwere the same as those
of the buffer control. In contrast, TAMU104 cells expressing het-
erodimeric Tsr with only one ligand-binding site responded with
increased MMC values at DHMA concentrations of up to 5 mM,
although they reached their plateau value of 0.40 to 0.5 at a 0.5M
concentration of DHMA, as was the case with CV1 cells. This
result is consistent with the idea that DHMA interacts with the
second Tsr ligand-binding site to cancel out the attractant signal
evoked by binding at the first site. We saw no obvious increase
in tumbling at high concentrations of DHMA, which should be
reflected in lower MMC values. Therefore, binding to the sec-
ond site does not generate an obvious repellent response. Bind-
ing at the second site must occur with a lower affinity, as ex-
pected because of the negative cooperativity that exists between
the two sites (32, 37).
DISCUSSION
This study made the following discoveries. (i) The RP437 K-12
strain of E. coli exhibits chemotaxis to NE. This highly motile,
nonpathogenic strain possesses all of the chemoreceptors found in
EHEC (38) and shares the high-abundance chemoreceptors Tar
and Tsr with S. enterica. (ii) Chemotaxis to NE requires induction
of the periplasmic tyramine oxidase, TynA, and the aromatic al-
dehyde dehydrogenase, FeaB, through a signaling pathway that
requires the quorum-sensing histidine protein kinaseQseC. Thus,
the observed chemotaxis response toNE is indirect. (iii) DHMA, a
metabolite of NE that can potentially be made by the combined
activities of TynA and FeaB, is a potent chemoattractant for E. coli
K-12, with effective concentrations of 5 nM, suggesting that
chemotaxis to NE is actually chemotaxis to DHMA. (iv) DHMA is
sensed by the serine chemoreceptor Tsr. (v) Mutant variants of
Tsr defective in themajority (Tsr-T156K) orminority (Tsr-R69E)
half of the cross-dimer serine-binding site are defective in DHMA
chemotaxis. (vi) A heterodimeric receptor that consists of one
subunit of Tsr-T156K and one subunit of Tsr-R69E and has only
one functional serine-binding site mediates good chemotaxis to
DHMA. (vii) Cells expressing wild-type Tsr show a decreased re-
sponse to DHMA at concentrations above 50 M, whereas cells
expressing the Tsr-156K/Tsr-R69E heterodimer do not show a
decreased chemotaxis response at high concentrations of DHMA.
Although these results make the basic mechanism of chemotaxis
to NE and DHMA clear, they leave several questions unanswered.
Howcancells respond to such lowconcentrationsofDHMA?
Assuming equilibration between the concentrations of unbound
small molecules in the environment and the periplasm, at an ex-
ternal DHMA concentration of 5 nM there should be about 3
molecules of free periplasmic DHMA (see Materials and Meth-
ods). Diffusion of small molecules trapped within the periplasmic
space is very rapid, so localization of the chemoreceptors at sub-
polar patches (39) should not be limiting for the kinetics of detec-
tion of DHMA. If Tsr binds DHMA very tightly, then the number
of Tsr receptors occupied by DHMA at 5 nM DHMA may be
considerably larger than 3. In any case, the response to DHMA is
exquisitely sensitive.
The binding of one additional attractant molecule per second
is adequate to cause a measurable increase in counterclockwise
flagellar bias (40, 41). Rates of change in bound DHMA should
certainly occur in cellsmoving laterally in the steep gradients pres-
ent in the observation chamber of our microflow device. The sen-
sitivity of the response is enhanced by the high level of amplifica-
tion seen within the receptor patch (the activity of 35 CheA
kinases inhibited per molecule of attractant bound [28]) and by
the high positive cooperativity (Hill coefficient of11) in adjust-
ing the rotational bias of the flagellar motor to changes in intra-
cellular CheY-phosphate (42).
Why is the microflow assay ideal for studying chemotaxis to
biological signals? The observation chamber in the microflow
assay is only 20mhigh. Thus, chemotaxis in themicroflow assay
is essentially a two-dimensional excursion. This geometry may
provide a good simulation of the spatial context in which che-
motaxis occurs in the intestine. The physiologically relevant re-
sponse to NE or its metabolites in the intestine could be largely a
surface phenomenon that occurs when the cells swim within or
under themucosal layer, which is only a fewhundredmicrometers
thick and lies in close proximity to the intestinal epithelium. The
gradients in the microflow assay can be made very steep, a condi-
tion that may also reflect the situation in vivo. With conventional
assays for chemotaxis, it is unlikely that we could have observed a
response that peaks at 5 to 50 MDHMA and then disappears at
higher concentrations.We anticipate that themicroflow assay will
be suitable for screening bacterial chemotaxis to a wide range of
biological signaling molecules in a spatial and temporal context
similar to that in which chemotaxis probably occurs in the host
intestine.
Why do cells respond only to low concentrations of DHMA?
Unlike the typical situation, in which responses plateau at high
FIG 8 MMC values for different tsr mutants in exponential gradients from 0
to the indicated concentration of DHMA or serine, in M. Strains: CV1, wild
type; TAMU104, strain with chromosomal tsr-T156K and plasmid-borne,
salicylate-inducible tsr-R69E. The DHMA data for CV1 are an extension of
those shown in Fig. 7B. Error bars represent the standard deviations of the
means for results from triplicate experiments.
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concentrations of attractant, the smooth-swimming response to
DHMA disappears at higher concentrations (Fig. 8). This effect is
not seen if the second of the two ligand-binding sites of the Tsr
homodimer is eliminated, as in the R69E/T156K heterodimer
(Fig. 6B). One possible explanation is that DHMA binds to the
second site with negative cooperativity (32, 37) and, by so doing,
cancels out the attractant signal generated by binding to the first
site. The mechanism for this phenomenon remains to be eluci-
dated, but in vivo it would be expected to cause cells to congregate
in regions with intermediate concentrations of DHMA.
Is NE/DHMA chemotaxis an important factor in gut-mi-
crobe interactions? The DHMA that bacteria encounter in the GI
tractmay be generated by the host or by bacterialmetabolism. The
ability of NE to induce the synthesis of bacterial enzymes that
convert NE to DHMA suggests that resident bacteria may play an
important role in generating localized DHMA gradients. Because
FeaB and the other aldehyde dehydrogenases are presumably con-
fined to the cytoplasm, to respond toNE theDOPEGAL generated
by periplasmic TynA would have to be taken up by the cells and
converted to DHMA, which would then have to be released back
into the periplasm. A similar mechanism is observed for E. coli
chemotaxis to lactose (43). Lactose must be taken up into the cell
by lactose permease (44) and split into glucose and galactose by
-galactosidase (45). One or both of these monosaccharides must
then reenter the periplasm and bind to the MglB binding protein
(46), which then has to interact with the Trg chemoreceptor (47).
However, in the intestine, motile cells probably respond to
DHMA gradients generated by bacteria that have already colo-
nized the intestinal epithelium. Thus, sensitivity to low concen-
trations of DHMA is consistent with the idea that chemotaxis to
DHMA has biological significance.
Endogenous DHMA production is normally low in sympa-
thetic neuronal tissues (26), but it may be produced from NE by
bacteria that have already colonized NE-rich areas on the intesti-
nal epithelium. Among such sites would be the Peyer’s patches
near the junction of the jejunum and ileum, which are favored
locations for colonization and invasion by enteric bacteria (48).
By navigating to loci of NE leakage, cellsmay encounter the higher
concentrations of NE that are required for induction of virulence
genes (6). Furthermore, stress increases release of NE by the sym-
pathetic innervation of the gut and heightens the severity of bac-
terial infection in the GI tract (7), and high levels of NE enhance
growth of E. coli in serum-based media in vitro (13). This effect is
also seen as a temporary and reversible increase in fecal coliforms
in the mouse intestine in the presence of pharmacologically in-
duced high levels of NE in the mouse (14). The combination of
induction of virulence genes by NE and chemotaxis to its metab-
olite DHMA may work together to heighten the pathogenicity of
enteric bacteria that possess a Tsr-like chemoreceptor.
It is intriguing that the serine receptor Tsr, typically reported to
be the most abundant of the E. coli chemoreceptors (49), also
senses two biological signaling molecules, the intradomain quo-
rum-sensing compound AI-2 (50) and the interdomain signaling
molecule DHMA. It is exciting to contemplate that microfluidic
assays may uncover other secrets about old friends in the che-
motaxis signaling pathways of bacteria.
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